Corient Private Wealth’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.59M Sell
19,114
-3,454
-15% -$983K 0.01% 731
2026
Q1
$3.9M Sell
22,568
-5,468
-20% -$1.12M 0.01% 942
2025
Q4
$7.18M Buy
28,036
+57
+0.2% +$14.9K 0.01% 650
2025
Q3
$7.28M Buy
27,979
+1,224
+5% +$322K 0.01% 592
2025
Q2
$6.54M Sell
26,755
-1,168
-4% -$291K 0.01% 629
2025
Q1
$7.39M Buy
27,923
+1,133
+4% +$306K 0.01% 579
2024
Q4
$6.8M Sell
26,790
-48,322
-64% -$13M 0.01% 613
2024
Q3
$23.8M Buy
75,112
+43,277
+136% +$15.4M 0.04% 393
2024
Q2
$11.9M Buy
31,835
+3,987
+14% +$1.35M 0.02% 487
2024
Q1
$9.66M Buy
27,848
+388
+1% +$147K 0.02% 534
2023
Q4
$12.6M Buy
27,460
+60
+0.2% +$29.6K 0.02% 473
2023
Q3
$13.3M Sell
27,400
-402
-1% -$189K 0.03% 426
2023
Q2
$12.4M Buy
27,802
+741
+3% +$373K 0.03% 435
2023
Q1
$13.1M Buy
27,061
+9,872
+57% +$4.88M 0.04% 393
2022
Q4
$8.81M Buy
+17,189
New +$9.03M 0.03% 391

Other funds holding HUM

Corient Private Wealth's HUM Position: Q2 2026 in Review

Corient Private Wealth reduced its Humana (HUM) stake by 15% in Q2 2026, selling an estimated $983K and leaving 19,114 shares worth $7.59M. The position accounts for 0.01% of the portfolio, ranked #731.

Corient Private Wealth first reported a position in HUM in Q4 2022 and has held it in 15 quarters since. The position peaked at $23.8M in Q3 2024. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Corient Private Wealth held 19,114 shares of Humana worth $7.59M as of Q2 2026.
  • Corient Private Wealth sold 3,454 Humana shares in Q2 2026, an estimated $983K.
  • Humana made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #731 holding.
  • Corient Private Wealth first reported a position in Humana in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Humana position peaked at $23.8M in Q3 2024.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.